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Abstract 
Rationale/Objectives: Recent theoretical models suggest that the central executive 
may not be a unified structure. The present study explored the nature of central 
executive deficits in ecstasy users. Methods: In Study One, 27 ecstasy users and 34 
nonusers were assessed using tasks to tap memory updating (computation span; letter 
updating) and access to long-term memory (a semantic fluency test and the Chicago 
word fluency test). In Study Two, 51 ecstasy users and 42 nonusers completed tasks 
that assess mental set switching (number/letter and plus/minus) and inhibition 
(random letter generation). Results: MANOVA revealed that ecstasy users performed 
worse on both tasks used to assess memory updating, and on tasks to assess access to 
long-term memory (C- and S-letter fluency). However, notwithstanding the 
significant ecstasy-group related effects, indices of cocaine and cannabis use were 
also significantly correlated with most of the executive measures. Unexpectedly, in 
Study Two, ecstasy users performed significantly better on the inhibition task 
producing more letters than nonusers. No group differences were observed on the 
switching tasks. Correlations between indices of ecstasy use and number of letters 
produced were significant. Conclusions:  The present study provides further support 
for ecstasy/polydrug related deficits in memory updating and in access to long-term 
memory. The surplus evident on the inhibition task should be treated with some 
caution as this was limited to a single measure and has not been supported by our 
previous work.  
 
Keywords: ecstasy, MDMA, cannabis, cocaine, memory updating, switching, 
inhibition, executive function.  
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Introduction 
The increasing popularity of the recreational drug ecstasy (MDMA) is of 
much concern. The drug elicits pharmacological effects through the release of 
serotonin (among other neurotransmitters) in the brain (McDowell & Kleber, 1994) 
and has a strong neurotoxic potential on serotonergic terminals in animals (Ricaurte et 
al, 1992, 2000), which may also occur in humans (Bolla et al, 1998; Klugman et al, 
1999; Reneman et al, 2001). Thus, it may follow that these serotonergic depletions 
manifest themselves as disturbances in mood (e.g. Curran and Travill, 1997; Fox et al, 
2001) and cognition (e.g. Bolla et al, 1998; Morgan, 1999; Wareing et al, 2000; 
Wareing et al, 2004a; Wareing et al, 2004b).  
Cognitive deficits in ecstasy users are reported frequently over a wide range of 
tasks. The working memory system in general, and the executive system in particular 
appear to be affected. However, it remains unclear why ecstasy users may be impaired 
in some “executive function” tasks, and not others. Fox et al (2001) assessed the 
performance of a group of ecstasy users who reported experiencing cognitive deficits, 
and those who did not report such problems. Paradoxically, non-problem users were 
found to have significantly longer Tower of London (TOL) planning times than the 
problem users and the control group. Both ecstasy groups made significantly more 
errors than controls on a spatial working memory task, while higher use of ecstasy 
was associated with longer TOL planning times. Testing executive function and 
spatial working memory, Fox et al (2002) found that ecstasy users performed worse 
than controls on verbal fluency, spatial working memory, attention shifting and 
pattern recognition. Moving on to verbal working memory, Wareing, et al (2004a) 
found that previous and current users of ecstasy were impaired on a computation span 
task, requiring the concurrent processing and updating of information in working 
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memory. The main effect of ecstasy remained significant after control for the use of 
other drugs. However, no ecstasy related deficits were observed on the reading span 
task, which supposedly uses the same mechanism. Wareing, et al (2000) also found 
ecstasy users to be impaired in a random letter generation task, but no such effect was 
found in a subsequent study (Fisk et al, 2004). While the results of such studies 
suggest global working memory deficits in ecstasy users, some studies fail to find 
ecstasy related cognitive deficits. Turner, et al (1999) found that ecstasy users were 
unimpaired on the WCST (replicated by Fox et al, 2001), while Morgan et al, (2002) 
found ecstasy users to be unimpaired in word fluency, Stroop, and Subtracting Serial 
Sevens among other tests. Von Geusau et al. (2004) also found that ecstasy users were 
unimpaired on the stop signal reaction time task (believed to measures response 
inhibition).   
Recent theoretical models of executive functioning postulate that the central 
executive is fractionated, with its different components performing separate tasks with 
varying degrees of competence. Miyake et al. (2000) studied the separability of three 
supposed executive functions: mental set shifting (“shifting”), information updating 
and monitoring (“updating”), and inhibition of pre-potent responses (“inhibition”), 
and how they contributed to executive tasks. Structural equation modelling revealed 
that the three executive functions were moderately correlated with each other, but 
clearly separate, and they contribute differently to performance on various executive 
prefrontal tasks. For example, the Wisconsin Cart Sort Task (WCST) was linked to 
the shifting component, the Tower of Hanoi to the inhibition component, random 
number generation to both the inhibition and updating components, and operation 
span to the updating component.  
 5 
 Furthermore, utilising Miyake et al’s conceptualisation, we have suggested in 
previous studies that it is the updating component of working memory, and not the 
shifting and inhibition elements that are most susceptible to the effects of ecstasy 
(Montgomery et al, 2004; Montgomery et al, 2005; Montgomery et al, in press; 
Wareing et al, 2004a). Consistent with this proposition, Verdejo-Garcia et al (2005) 
found that ecstasy use was an important contributory factor in deficits in working 
memory updating among a clinical sample of poly-substance abusers. Similarly 
research from our own laboratory demonstrates that ecstasy users are impaired on 
tasks such as computation span (Fisk et al 2004), which is also known to load on the 
updating executive function (Fisk & Sharp, 2004).  Equally it appears that tests 
sensitive to the shifting and inhibition elements do not appear to be as consistently 
susceptible to the effects of ecstasy (e.g. Fisk et al, 2004; Fox et al, 2001; Fox et al, 
2002; Godolphin & Parrot, 1999, cited in Parrot, 2000; Gouzoulis-Mayfrank et al, 
2000; McCardle et al, 2004; Thomasius et al, 2003; but also see von Geusau et al 
2004).  
To date there has been no systematic investigation of whether or not ecstasy 
users are impaired in the different aspects of executive functioning identified by 
Miyake et al (2000). Existing research findings are piecemeal and have not always 
made use of the traditional measures of the different executive subcomponents 
identified by Miyake et al (2000). Therefore, the present study sought to ascertain the 
nature of executive function deficits in a sample of recreational ecstasy users. We 
aimed to use “pure” measures of each of the three postulated executive functions 
(updating, shifting and inhibition), and provide further clarification of the nature of 
executive deficits in ecstasy users. In a study of cognitive ageing, Fisk and Sharp 
(2004) provided further support for Miyake et al’s model. Factor analysis revealed 
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that certain tasks loaded on each of the three components identified by Miyake et al, 
but there was also a distinct executive function loading on another factor, which Fisk 
and Sharp termed access to long-term memory (although age was not a significant 
predictor of performance on “access” tasks). Previous research has shown that ecstasy 
users exhibit deficits in word fluency, which is reliant on the executive function of 
access to long-term memory (Baddeley, 1996). However, this task also reveals 
equivocal results, with some studies finding ecstasy related deficits and others not 
(e.g. Bhattachary and Powell, 2001; Curran and Verheyden, 2003; Croft et al, 2001; 
Fox et al, 2002; Heffernan et al, 2001). Thus the present study also sought to further 
investigate word fluency deficits among ecstasy users. The verbal fluency task used 
here, the Chicago word fluency test, is an established measure of prefrontal executive 
functioning (Kolb & Whishaw, 1985). The test imposes longer time limits and places 
further constraints on the categories used, thereby increasing the potential load on 
executive resources.  
Poorer performance in certain tasks may provide further support for frontal 
lobe impairments among ecstasy users. For example, while performance on a 
switching task has been linked to the anterior cingulate cortex (Posner and Raichle, 
1994), the left frontal lobe (Rogers et al, 1998) and the bioccipital and parietal lobes 
(Moulden et al, 1998), performance on a response inhibition task has been linked to 
the pre-frontal cortex (Casey et al, 1997; Kiefer et al, 1998), and damage to the 
inferior frontal gyrus (Aron et al. 2003). Likewise, deficits in updating may support an 
MDMA related deficit in the dorsolateral prefrontal cortex (Goldman-Rakic, 1996) or 
the left fronto-polar cortex (Van-der-Linden et al, 1999).   
 We are aware that there are other postulated executive functions. The four we 
have picked to investigate are low-level behaviours that are easily operationally 
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defined, and easy to measure (unlike for example planning). It is also likely that other 
more complex executive tasks will rely on these functions.   
Therefore, the present study sought to systematically investigate ecstasy 
related deficits in the shifting, inhibition, updating, and access to long-term memory 
elements of the central executive. Given the nature of ecstasy poly-drug use, it is 
possible that any observed deficits in cognitive functioning may be in part attributable 
to the concomitant use of “other” drugs (e.g. Croft et al. 2001). Indices of the 
frequency and intensity of other drug use will be collected and where possible, we 
shall attempt to evaluate the impact of these on the executive measures included in the 
present study. 
It was calculated that data collection using all the appropriate measures would 
take a considerable amount of time per session. Therefore to counter boredom and 
fatigue effects the tasks were divided into two research studies, Study One to 
investigate updating and access to long-term memory, and Study Two to investigate 
switching and inhibition.   
 
STUDY 1 
 
Study 1 investigated the updating executive component process and access to 
long-term memory. It was predicted that ecstasy users would perform worse than non-
users on measures of updating (a running memory task and computation span) and on 
access to long-term memory (a word fluency task).  The letter-updating task is widely 
accepted as an established pure measure of the memory updating function. The task is 
a key indicator of Miyake et al’s conceptual framework, and has not been used in 
research with ecstasy users before. Although word fluency has been assessed in 
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samples of ecstasy users (e.g. Bhattachary and Powell, 2001; Fox et al, 2002), the task 
used in the present study is more likely to recruit executive prefrontal resources as it 
is a longer version than previously used and places further constraints on the 
categories thus making it harder for participants. To our knowledge, this task has not 
been used in research with ecstasy users before.  
 
Method 
 
Design.  
With regard to the updating executive component process, a multivariate 
design was used, with ecstasy user group (2 levels) as the between groups variable, 
and the updating measures (letter updating and computation span) as the dependent 
variables. (For the letter-updating task, a single composite measure was calculated 
following the procedure adopted by Fisk and Sharp, 2004). Letter span was also 
measured and incorporated into ANCOVA, to remove the mediating effects of 
differences in simple span. A multivariate design was used for the word fluency tasks, 
with ecstasy user group as the between participants independent variable, and the 
three word fluency scores (semantic, “S” letter, and C” letter) as the dependent 
variables.  
 
Participants  
Twenty-seven ecstasy users (mean age 21.70; 14 male) and 34 non-user 
controls (mean age 21.59; 10 male) completed the updating and word fluency tasks. 
Participants were recruited via direct approach to university students, and the 
snowball technique (Solowij et al, 1992). With 27 ecstasy users, the present sample is 
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sufficient to detect a difference of between 0.75 and 1σ for α = .05 and β =.20 (Hinkle 
et al, 1994). Participants were requested to refrain from ecstasy use for at least 7 days 
and ideally 10 days prior to testing (the mean period of abstinence was actually 5 
weeks, median abstinence period 2 weeks). Participants were also requested not to use 
any other illicit drugs for at least 24 hours and ideally for 7 days prior to testing.   
 
Materials  
Patterns of drug use and other relevant lifestyle variables were investigated via 
means of a background questionnaire. The questionnaire gauged the use of ecstasy 
and other drugs, as well as age, years of education, general health and other relevant 
lifestyle variables. In relation to other drugs, participants were asked a range of 
questions including frequency and duration of use and the last time that they had used 
each drug. Participants were also questioned concerning their history of drug use, and 
using a technique employed by Montgomery, et al (2005), these data were used to 
estimate total lifetime use for each drug. Average weekly dose and the amount of each 
drug consumed within the previous 30 days were also assessed. Fluid intelligence was 
measured via Raven’s Progressive Matrices (Raven et al, 1998), and premorbid 
intelligence was assessed via the National Adult Reading Test (NART, Nelson, 1982).   
Sleep Quality: A screening questionnaire and the Epworth Sleepiness Scale 
(ESS, Johns, 1991) were used to investigate any group differences in sleep quality. 
The ESS is a measure of subjective daytime sleepiness and contains eight items, 
which a participant has to score on a scale of 0 (would never doze off in this situation) 
to 3 (high chance of dozing off in this situation). A total score of all eight items was 
used in the analysis, and a high score was indicative of increased subjective daytime 
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sleepiness. The screening questionnaire contained a number of questions on sleep 
quality, e.g. hours per night.   
Letter Span: Consonants were presented sequentially on a computer screen for 
1.25 seconds. Participants were then required to recall the letters in the order in which 
they were presented. The task commences with three sets of two letters, and is then 
increased to three sets of three, four, five etc., until the individual fails on at least two 
out of three trials.  
Consonant Updating: This task was based on the running memory task (Morris 
and Jones, 1990). In this computer-based task, the participant was presented with a 
random sequence of between 6 and 12 consonants on a computer screen. Twenty-four 
such lists were presented, and in each case, the participant was unaware of the number 
of consonants to be presented. The task was always to recall the most recent six 
consonants in the order in which they were presented. The participant experienced six 
trials at each of the four list lengths: 6, 8, 10, and 12 items. The order in which the 
lists were presented was randomised. A single composite score of updating was 
calculated as in Fisk and Sharp (2004).  
Computation Span. Computation span has been used extensively as an 
indicator of working memory functioning in the cognitive ageing literature (Fisk & 
Warr, 1996; Salthouse & Babcock, 1991) and it is similar to the operation span 
measure used by Miyake, et al (2000) in their investigation of executive processes. 
Participants were required to solve a number of arithmetic problems (e.g., 4+7 = ?) by 
circling one of three multiple-choice answers as each problem was presented. They 
were also required to simultaneously remember the second digit of each presented 
problem. At the end of each set of problems the second digits had to be recalled in the 
order in which they were presented. The number of arithmetic problems that the 
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participant had to solve, while at the same time remembering each second digit, 
gradually increased as the test proceeded. For each of the first three trials only a single 
problem was presented. For the next three trials, two problems were presented. 
Subsequently, the number of problems presented per trial increased by one every third 
trial. In order to proceed, the participant was required to be correct in at least two of 
the three trials at the current level. Computation span was defined as the maximum 
number of end digits recalled in serial order, with the added requirement that the 
corresponding arithmetic problems had been solved correctly.  
Semantic Fluency: In the semantic fluency task, participants were required to 
recall as many animal names as they could think of. This could be different species, or 
breeds within species. Participants were given four minutes for this task.  
Chicago Word Fluency Test. Participants were instructed not to write any 
place names, peoples name or plurals in this test. Firstly participants were given five 
minutes to write down as many words as they could, beginning with the letter “S”. 
Secondly, they were given four minutes to write down as many four-letter words 
beginning with “C” as they could. As plurals were not allowed, words such as “ cats”, 
and repetitions of words were excluded. Scores for all three fluency tasks were the 
number of appropriate words in each case. 
 
Procedure  
Participants were informed of the general purpose of the experiment, and 
written informed consent was obtained. The tests were administered under laboratory 
conditions, and a computer running MS-DOS was used for the computer based tasks. 
The tests were administered in the following order: background questionnaire, sleep 
questionnaires, NART, letter span, consonant updating, semantic fluency, word 
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fluency, and Raven’s progressive matrices. Participants were fully debriefed, paid £15 
in store vouchers, and given drugs education leaflets. The study was approved by the 
Ethics Committee of Liverpool John Moores University, and was administered in 
accordance with the ethical guidelines of the British Psychological Society.  
 
RESULTS 
 
The scores for background measures are set out in Table 1. An initial t-test revealed 
that there were no significant differences between the groups in age, pre-morbid 
intelligence, sleep (hours per night), years of education, self-rated health or Raven’s 
Progressive Matrices (although the latter approached significance, p=0.06). Ecstasy 
users did however report higher subjective daytime sleepiness, measured by the 
Epworth Sleepiness Scale, t(58)= 2.06, p<.05.  
 
   <<Insert Table 1 About Here>>     
 
The main effect of ecstasy use on memory updating was statistically significant, 
F(2,58)= 3.19, p<.05 for Pillai’s Trace. Separate univariate analyses revealed that this 
was due to ecstasy users performing worse than controls on both the letter updating 
(F(1,59)=5.15, p<.05) and computation span (F(1,59)=3.21, p<.05, one-tailed) tasks. 
The main effect of ecstasy use on word fluency was also significant, F(3,57)=3.20, 
p<.05, for Pillai’s Trace. This was due to ecstasy users’ poorer performance on the 
“S” letter, F(1,59)=6.15, p<.05, and the “C” letter categories, F(1,59)=8.81, p< .005. 
There were no significant differences between the groups on the semantic fluency 
task.  
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   <<Insert Table 2 About Here>> 
 
Inspection of Table 3 shows that the use of other drugs was limited mainly to the use 
of cannabis, alcohol, and tobacco among the non-ecstasy group. The ecstasy users had 
a lifetime dose of cannabis twice that of the non-users (2634 joints to 1317 joints), in 
addition to using it more frequently (2.57 times a week, compared to 0.95 times a 
week), having smoked more in the last 30 days (22.66 joints compared to 9.58 joints), 
and having a larger average weekly dose (10.17 joints compared to 6.40 joints). In 
relation to the cannabis measures, t-test revealed that the group difference was 
statistically significant only for frequency of use variable: t(25.56) = 2.56, p<.05 (As 
Levene’s test was significant, degrees of freedom have been adjusted accordingly).  
 
   <<Insert Table 3 About Here>> 
 
Correlations with Indices of Drug Use. 
Due to the small number of illicit drug users among the non ecstasy user group 
it was not possible to control statistically for the effects of other drugs through the use 
of ANCOVA. Therefore it is possible that some or all of the ecstasy-related effects 
might have been attributable to the effects of other drugs. To address this possibility, 
correlations were performed with different measures of ecstasy, amphetamine, 
cannabis and cocaine use. Measures of lifetime use of each drug, the number of times 
each drug was consumed each week, the amount of each drug consumed within the 
last 30 days, and the average weekly dose (i.e. total amount consumed divided by the 
length of use in weeks)
 
were all included
1
. For each of these a value of zero was 
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entered for nonusers of the drug in question. In addition, for each illicit drug, a 
categorical variable in which users and nonusers of each drug were coded as 0 or 1 
respectively was included.  
A full Bonferroni correction is not appropriate in this case, as the performance 
measures are intercorrelated (Sankoh et al. 1997). However multiple comparisons 
remain potentially problematic, therefore an intermediate level of correction has been 
used, with correlations being evaluated at p<.01. The results, set out in Table 4, show 
that ecstasy use was significantly correlated with a number of the performance 
measures. Total ecstasy use, average dose of ecstasy and amount used in the last 30 
days were significantly negatively correlated with  “C” letter fluency (at p<.01), while 
amount used in the last 30 days was also negatively correlated with “S” letter fluency 
(p<.01).  Finally, the categorical ecstasy user/nonuser variable was significantly 
positively correlated  “C” letter fluency at p<.01. 
In relation to other drugs, total cannabis use, frequency of use and average 
cannabis dose were significantly negatively correlated with computation span (p<.01), 
and cannabis user/nonuser was significantly positively correlated with computation 
span (p<.01). Indices of cocaine use were also significantly negatively correlated with 
task performance: Total use, frequency of use and average dose with “C” letter 
fluency (at p<.01), frequency of use with “S” letter fluency (p<.01), and the 
user/nonuser variable with “C” letter fluency at p<.01.  
   <<Insert Table 4 About Here>> 
It is clear from the correlations that aspects of cocaine use may have 
contributed or possibly caused the observed ecstasy-related deficits in word fluency 
observed in the present study. To evaluate the potentially confounding effects of 
cocaine we performed several analyses with a categorical cocaine user/nonuser 
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independent variable, with those reporting that they had ever tried cocaine, N=25 
versus those who reported that they had never tried cocaine, N=36, which would 
enable us to compare effect sizes for ecstasy versus cocaine analyses. Cocaine 
user/nonuser was non-significant for letter updating, F(1,59) = .95, p>.05, and 
computation span, F(1,59) = 1.81, p>.05. With reference to word fluency, the 
multivariate cocaine-related effect was significant, F(3,57) = 3.72, p<.05. Separate 
univariate analyses revealed that cocaine users performed significantly worse on the 
“S” and “C” letter fluency tasks, F(1,59) = 5.77; 11.33, p<.05 and p<.001 
respectively. To try and compare cocaine and ecstasy group-related effects on word 
fluency, we compared the effect sizes for the two sets of analyses (as cocaine 
user/nonuser was non-significant for computation span and letter updating, and 
ecstasy user/nonuser was, effect sizes for these analyses are not reported). The 
multivariate effect size was larger for cocaine user than for ecstasy user (partial Eta 
squared of 0.164 and 0.144 respectively), as was the “C” letter effect size (partial Eta 
squared of 0.161 and 0.130 respectively), the effect size for “S” letter fluency was 
marginally larger for ecstasy (partial Eta squared of 0.094) than for cocaine (partial 
Eta squared of 0.089). This is consistent with either a cocaine-related word fluency 
deficit, or an exacerbated cocaine/ecstasy deficit in word fluency, although it is still 
likely that performance on the letter updating and computation span tasks are related 
to aspects of ecstasy use.  
Covariate Analyses. 
As ecstasy users scored significantly higher than non-ecstasy users on the ESS 
and group differences on the Raven’s Progressive Matrices approached significance 
(indicating a more pathological sleep pattern and higher IQ respectively), ANCOVA 
was conducted to investigate the possible mediating effects of sleep and intelligence 
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on memory updating and word fluency. The multivariate effects of the ESS were non-
significant (p>.05), however, the effects of fluid intelligence were highly significant: 
F(2,55) = 7.58, p<.001, for Pillai’s Trace. The main effect of ecstasy use on memory 
updating was enhanced after removing the variance due to fluid intelligence: F(2,55) 
= 6.37, p<.005, for Pillai’s Trace. Univariate analyses revealed that although fluid 
intelligence was significantly associated with both computation span and updating 
performance: F(1,56) = 9.00; 9.46, p<.005 respectively, the effects of ecstasy use on 
computation span and updating were heightened when variance due to fluid 
intelligence was removed: F(1,56) = 6.05; 9.37, p<.05 and .005 respectively. 
Homogeneity of regression was achieved with respect to both covariates, p>.05 for 
the group covariate interaction in both cases.  
 With reference to word fluency, ANCOVA with ESS and Raven’s Progressive 
Matrices scores as covariates revealed that the multivariate effects of these variables 
were non-significant (p>.05 in both cases). The multivariate ecstasy effect remained 
significant after control for these covariates, F(3,54) = 2.36, p<.05 one-tailed, for 
Pillai’s Trace. Univariate analyses revealed that the effects of ecstasy use on “S” and 
“C” word fluency remained significant after control for ESS and Raven’s scores: 
F(1,56) = 4.04; 7.21, p<.05, .01 respectively. Again, homogeneity of regression was 
achieved with respect to both covariates, p>.05 for the group covariate interaction in 
both cases. 
 Although there were no significant group differences in letter span, it was 
possible that the effect of ecstasy use on the letter-updating task could in part be 
mediated by letter span. To address this possibility letter span was entered as a 
covariate. The effects of letter span fell just short of significance: F(1,58) = 3.47, 
p=.068. The main effect of ecstasy use on letter updating remained significant after 
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control for letter span, F(1,58) = 5.10, p<.05.  Homogeneity of regression was 
achieved with respect to this covariate, p>.05 for the group covariate interaction.  
 Finally, as there was a gender imbalance between the two groups, ANCOVA 
was performed with gender as a covariate. Although the multivariate effect of gender 
was significant for updating, F(2,57) = 3.25, p<.05 for Pillai’s Trace, the multivariate 
effect of ecstasy use remained significant for updating after control for gender, 
F(2,57) = 4.96, p<.01, for Pillai’s Trace.  Subsequent univariate analyses revealed that 
the effects of ecstasy use on letter updating and computation span also remained 
significant, F(1,58) = 7.57; 5.03, p<.01; .05 respectively. The multivariate effect of 
gender on word fluency was non-significant (p>.05) and the multivariate effect of 
ecstasy use on word fluency remained significant after control for gender, F(3,56) = 
3.11, p<.05, for Pillai’s Trace. The effects of ecstasy use on S- and C-letter fluency 
remained significant after control for gender, F(1,58) = 6.39; 8.79, p<.01; .005 
respectively. Homogeneity of regression was achieved with respect to this covariate, 
p>.05 for the group covariate interaction. 
Implications: Study 1 supports an ecstasy-related deficit in memory updating 
and access to long-term memory that is not related to gender, intelligence, 
amphetamine use, or sleep quality. However, it is possible that access to long-term 
memory (as indexed by the word fluency scores) is also sensitive to aspects of cocaine 
use. Indeed Table 4 reveals that among ecstasy users, in the majority of cases outcome 
measures were more related to aspects of cocaine use than they were to the equivalent 
indices of ecstasy use. With regard to the updating executive component process, 
contrary to expectations, indices of cannabis use appear to be related to performance 
on the computation span task.  It is equally noteworthy that while MANOVA yielded 
significant ecstasy-related group differences, none of the measures of ecstasy use 
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were significantly correlated with computation span nor letter updating performance 
at the adjusted level of α = .01. 
 
STUDY 2 
Study 2 assessed the shifting and inhibition components of the executive. Two tests 
which tap shifting were used (plus-minus task, and number/letter task). Consistent 
with previous research that suggests ecstasy users are not impaired in switching (e.g. 
Fox et al, 2001; Turner et al, 1999) it was expected that both groups would have 
similar shift-cost latencies, and that ecstasy users would not perform worse than non-
users in these tasks. Inhibition was measured via the random letter generation task 
(Baddeley, 1996). Again consistent with previous research (Fisk et al 2004) it was 
expected that ecstasy users would not perform worse than non-users on the random 
generation task.  
 
Method. 
 
Design.  
A multivariate design was used for the switching measures with ecstasy user 
group (2 levels) as the between participants independent variable, and the shift cost 
latencies (seconds) as the dependent measures. Miyake et al (2000) found that random 
number generation loaded on the inhibition and updating components of the executive 
system. We used random letter generation to measure inhibition, which is analogous 
to the random number generation task but which Fisk and Sharp (2004) maintain 
loads on inhibition but not on updating. For the random generation task, MANOVA 
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was used with ecstasy user group as the between participants variable, and the four 
random letter generation scores as the dependent measures.  
 
Participants  
Fifty-one ecstasy users (mean age 21.96, 27 male) and 42 nonuser controls 
(mean age 20.83, 9 male) were recruited via direct approach to university students, 
and the snowball technique (Solowij et al, 1992). With 42 nonuser controls, the 
present sample is sufficient to detect a difference of between 0.5 and 0.75 σ for α = 
.05 and β =.20 (Hinkle et al, 1994). Participants were requested to refrain from 
ecstasy use for at least 7 days and ideally 10 days prior to testing (the mean period of 
abstinence was actually 22 weeks, median abstinence period 4 weeks). Participants 
were also requested not to use any other illicit drugs for at least 24 hours and ideally 
for 7 days prior to testing. None of the participants were involved in the first study. 
 
Materials  
Background questionnaires, intelligence tests and sleep quality tests were used 
as in Study 1.  
Plus-minus task. The plus-minus task, adapted from Miyake et al (2000) 
consists of three lists of 30 two-digit numbers (the numbers 10-99, randomised). On 
the first list, participants were instructed to add three to each number, and write their 
answer in the box next to it. On the second list, participants were instructed to subtract 
three from each number. On the third list, participants were required to alternately add 
and subtract three from the list (i.e. add three to the first number, subtract from the 
second, and so on). List completion times were measured with a stopwatch. The cost 
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of shifting between adding and subtracting was calculated as the difference between 
the time for list three and the average of the times for lists one and two.  
Number-Letter task. In the number-letter task, adapted from Rogers and 
Monsell (1995) and Miyake et al (2000), a number letter pair (e.g.D4) is presented in 
one of four quadrants on a computer screen. If the target is in the top half of the 
screen, the task is to indicate if the letter is a vowel (A, E, I, O or U) or a consonant. If 
the target is in the bottom half of the screen, the task is to indicate if the number is 
odd or even. The practise version of the task comprises three sets. The target is 
presented in the top half of the screen for 12 trials, then the bottom half for 12 trials, 
and then in a clockwise rotation around all 4 quadrants for a further 12 trials. The 
main task follows the same structure, except there are 64 targets in each block. 
Therefore, the trials in the first two blocks required no switching, while the third set 
did. The shift-cost was the difference between the average reaction times of the third 
block and the averages of the first two blocks.   
Random letter generation. A computer display and concurrent auditory signal 
was used to pace responses. Participants were asked to speak aloud a letter every time 
the signal was presented. They were told to avoid repeating the same sequence of 
letters, to avoid producing alphabetical sequences, and to try to speak each letter with 
the same overall frequency. Individuals attempted to produce three sets of 100 letters; 
one set at a rate of one letter every 4 s, a second set at one letter every 2 s, and a third 
at one letter every 1 s. The order in which the sets were generated was randomised. 
The experimenter recorded the responses on an answer sheet. The test yields four 
scores. First, the number of alphabetically ordered pairs; second, a repeat sequences 
score corresponding to the number of times that the same letter pair is repeated; third, 
a “redundancy” score, which measures the extent to which all 26 letters of the 
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alphabet are produced equally often (0% being truly random); and fourth, the number 
of letters produced. In the first three cases, higher scores indicate poor performance; 
in the fourth the opposite is the case. The scores for each separate variable, at each of 
the three generation rates, were standardised. A single score for each random 
generation measure was produced by averaging the standardised scores for the three 
production rates. 
 
Procedure  
Participants were informed of the general purpose of the experiment, and 
written informed consent was obtained. The tasks were administered under laboratory 
conditions, and a computer running MS-DOS was used for the computer based tasks. 
The tests were administered in the following order: background questionnaire, sleep 
quality questionnaires, NART, random letter generation, plus-minus task, number-
letter task, and Raven’s progressive matrices. Participants were fully debriefed, paid 
£15 in store vouchers, and given drugs education leaflets. The study was approved by 
the Ethics Committee of Liverpool John Moores University, and was administered in 
accordance with the ethical guidelines of the British Psychological Society. 
RESULTS/DISCUSSION 
The scores for background variables are set out in Table 5. An initial t-test revealed 
that there were no significant differences between the groups in age, pre-morbid 
intelligence, Raven’s Progressive Matrices, the Epworth Sleepiness Scale, sleep 
(hours per night), years of education, or self-rated health, so these are not discussed 
any further.   
 
   <<Insert Table 5 About Here>>     
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Contrary to expectations, the main effect of ecstasy on inhibition was statistically 
significant, F(4,88) = 2.63, p<.05 for Pillai’s Trace. Separate univariate analyses 
revealed that this was due to ecstasy users producing more letters than non-users, 
F(1,91)= 8.29, p<.005. There were no differences between the groups on the other 
random letter generation scores of alphabetic sequences, repeat sequences and 
redundancy, F < 1 in all cases. The main effect of ecstasy use on switching was also 
non-significant, F < 1 for Pillai’s Trace. Separate univariate analyses revealed that 
there were no significant between group differences in performance on the plus/minus 
task or the number letter task, F < 1 in both cases.     
 
   <<Insert Table 6 About Here>> 
 
Inspection of Table 7 shows that the use of other drugs among the non-ecstasy 
group was limited mainly to the use of cannabis, alcohol, and tobacco. The ecstasy 
users had a lifetime dose of cannabis many times that of the non-users (3544 joints to 
368 joints), in addition to using it more frequently (2.78 times a week, compared to 
0.94 times a week), having smoked more in the last 30 days (41.14 joints compared to 
17.29 joints), and having a larger average weekly dose (9.10 joints compared to 1.91 
joints). A t-test revealed that all these differences between the groups except amount 
used in the last 30 days were statistically significant: t(43.40; 40.80; 50.79) = 4.42; 
3.27; 3.65, p<.005, for total, frequency and average dose respectively. (As Levene’s 
test was significant, degrees of freedom have been adjusted accordingly).  
 
    <<Insert Table 7 About Here>> 
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Correlations with Indices of Drug Use. 
There was no evidence of any ecstasy-related deficit on the inhibition and 
switching measures, although it is possible that other illicit drugs might exert an 
influence. To address this possibility, correlations were performed with different 
measures of ecstasy, amphetamine, cannabis and cocaine use. Measures of lifetime 
use of each drug, the number of times each drug was consumed each week, the 
amount of each drug consumed within the last 30 days, and the average weekly dose 
(i.e. total amount consumed divided by the length of use in weeks)
 
were all included
2
. 
For each of these a value of zero was entered for nonusers of the drug in question. In 
addition, for each illicit drug, a categorical variable in which users and nonusers of 
each drug were coded as 0 or 1 respectively was included.  
As in study 1, a full Bonferroni correction is not appropriate in this case, as the 
performance measures are intercorrelated (Sankoh et al. 1997). However multiple 
comparisons remain potentially problematic, therefore an intermediate level of 
correction has been used, with correlations being evaluated at p<.01. The results are 
set out in Table 8. Frequency of ecstasy use, average dose of ecstasy, and amount 
used in the last 30 days were significantly correlated with the number of letters 
produced (p<.01) . In all cases, increased ecstasy use was associated with more letters 
produced. No correlations with indices of other drug use were significant at p<.01.
  
   <<Insert Table 8 About Here>> 
Thus to summarize, the results of Study 2 suggest that ecstasy-related group 
differences are not apparent in task switching. Ecstasy users did however produce  
significantly more letters on the inhibition task, although there were no group 
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differences on the three other inhibition measures. This finding is not supported by 
previous research and should thus be treated with caution. 
GENERAL DISCUSSION. 
In the present paper, the conceptual framework of Miyake et al (2000) was 
used to assess executive function deficits in ecstasy users. The results demonstrate 
ecstasy/polydrug-group related deficits in memory updating and access to semantic 
memory. The ecstasy/polydrug users reached a lower level on the computation span 
task, and recalled fewer letters correctly on the letter-updating task. Ecstasy/polydrug 
users scored higher on an intelligence test and significantly higher on a sleep 
questionnaire, but the main effect of ecstasy/polydrug use remained significant after 
control for these covariates. Contrary to expectations ecstasy/polydrug users actually 
performed better than controls on the random letter generation task (used to measure 
inhibition), due to them producing more letters. There were no significant 
ecstasy/polydrug-related effects on the tasks used to measure switching. Thus the 
results of Studies 1 and 2 provide further support for ecstasy/polydrug-related deficits 
in memory updating (Montgomery et al, 2004; Verdejo-Garcia et al, 2005; Wareing et 
al, 2004a), and access to semantic memory, but not shifting (in contrast with von 
Geusau et al’s 2004 findings) or inhibition.  
The unanticipated effects of ecstasy on inhibition were due to ecstasy users 
producing more letters. However this should not be taken as evidence of an ecstasy 
related surplus since the three other measures of random letter generation: alphabetic 
and repeat sequences, and redundancy, failed to produce ecstasy group-related 
differences. Furthermore, other studies from our laboratory have not generated group-
related differences in the random generation measures (Fisk et al, 2004).  
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With regard to the word fluency measures, there were no ecstasy/polydrug-
related deficits on the semantic fluency category, and in addition, there were no 
significant correlations between the use of any drugs and semantic fluency. 
Ecstasy/polydrug users performed worse on the S- and C-letter categories (consistent 
with the results obtained by Bhattachary and Powell, 2001; Fox et al, 2002; and 
Heffernan et al, 2001). The deficit was more pronounced on the C-letter category. 
This may be because the further constraints (i.e. having to give four-letter words 
beginning with C) increase executive involvement, therefore making it more difficult. 
So, while ecstasy/polydrug users did not perform worse on the Semantic category (as 
this was relatively straightforward), performance declined as more rules were 
imposed on the categories. This finding suggests that ecstasy/polydrug group-related 
deficits are apparent in tasks that place greater demands on the central executive 
versus those where demands are relatively low. Poor performance on the word 
fluency task could represent a metacognitive deficit in ecstasy/polydrug users, 
whereby having no preestablished schema to achieve a particular goal in a novel 
situation such as this, they fail to select an appropriate strategy to solve the problem or 
find it difficult to monitor their performance and avoid breaking the rules (Ruff et al, 
1997). The word fluency task used in the present study imposed a longer limit 
compared to the verbal fluency tasks used in other studies (e.g. Fox et al, 2002). 
Therefore it is possible that the impaired fluency may relate to attentional deficits 
(with ecstasy/polydrug users failing to maintain attention during this longer version 
e.g. Jacobsen et al, 2003; McCardle et al, 2004).  
While the ecstasy/polydrug group were clearly impaired in access to semantic 
memory (as measured by the word fluency scores) it is difficult to attribute this deficit 
solely to ecstasy use. Indeed there is evidence that other drugs might play a key role. 
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Apart from ecstasy, aspects of cocaine use were also significantly associated with 
word fluency performance. Indeed it may be that the word fluency effects were a 
product of polydrug use. More specifically, since all of the cocaine users also used 
ecstasy it remains possible that the correlations observed relate to the joint use of the 
two substances. Equally while the present study suggests that there is a relationship 
between cocaine use and word fluency performance, this has only been demonstrated 
among ecstasy users. It remains to be seen whether the same pattern of associations 
apply among non-ecstasy users. Evidence of cocaine-related deficits in word fluency 
has been forthcoming (e.g. Strickland et al. 1993) and in view of the present findings 
an attempt to disentangle the relative effects of ecstasy and cocaine on this aspect of 
executive functioning would be an important area for future research.  
The level of other drug use among ecstasy users also made interpretation of 
the memory updating results difficult. While the MANOVA and ANOVA analyses 
yielded significant group-related differences, surprisingly, none of the correlations 
between indices of ecstasy use and the updating measures were statistically significant 
at the corrected significance level α = .01. Furthermore, measures of cannabis use 
rather than equivalent ecstasy use measures seem to be important predictors of 
computation span performance. While the significant relationship between 
computation span and aspects of cannabis use in consistent with cannabis related 
effects reported elsewhere (e.g., Croft et al, 2001) this finding should be treated with 
some caution as Fisk et al (2004) found that ecstasy-group related deficits in 
computation span remained statistically significant following control for various 
measures of cannabis (and other drug) use. Interestingly in contrast to the negative 
relationship between aspects of cocaine use and word fluency performance, measures 
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of cocaine use were not significantly correlated with letter updating and computation 
span performance. 
It has been suggested that ecstasy related cognitive deficits may be due to the 
fact that ecstasy users get less sleep (e.g. Cole et al, 2002b). In the present study, there 
were no group differences in self-reported hours of sleep per night. There were 
significant differences on the Epworth Sleepiness Scale, with ecstasy/polydrug users 
scoring higher than nonusers (indicating that they were more likely to doze off during 
the day). However, ANCOVA with this as a covariate left the main effect of 
ecstasy/polydrug use on memory updating and semantic fluency significant, 
suggesting that cognitive deficits in ecstasy/polydrug users are not mediated by 
differences in sleep quality. Although all participants were recruited from the 
university population, the ecstasy/polydrug -related group differences in Raven’s 
Progressive Matrices scores approached significance in Study 1, indicating that they 
have a higher IQ than nonusers. Controlling for differences in IQ increased the 
ecstasy-related deficits in updating and word fluency, suggesting that studies in which 
IQ has not been assessed may potentially underestimate the cognitive deficits (e.g. 
von Geusau et al, 2004). Although there was a gender imbalance between the user and 
nonuser groups, all significant main effects remained significant after control for 
gender. This suggests that in the present study, gender was not a significant 
contributory factor to cognitive impairment, and therefore contradicts some previous 
research findings (e.g. McCann et al, 1994; Liechti et al, 2001; Reneman et al, 2001; 
von Geusau et al, 2004).    
The focus of the present study was intended to be ecstasy use. However, a 
number of other illicit drugs consumed by the participants tested here appear to have 
produced effects on the measures that were administered. How might these effects be 
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explained? As research has shown that concomitant use of amphetamine by ecstasy 
users reduces the density of nigrostriatal dopamine neurones (Reneman et al, 2002), it 
is possible that the apparent cocaine effects in the present study may relate to the 
exacerbatory effects cocaine also has on the dopamine system, in ecstasy users. 
Unfortunately, as 21 out of 27 ecstasy users had tried cocaine, with 14 of these able to 
estimate their lifetime usage (compared to 4 and 0 in the non ecstasy group) the 
degree of overlap was such that it was not possible to state definitively whether the 
significant relationships that were observed were due to cocaine use or to the 
combined effects of cocaine and ecstasy.  
In Study 2, frequency of ecstasy use, average ecstasy dose, amount used in the 
last 30 days and the ecstasy user/non-user variable were significantly correlated with 
the number of letters produced. However, while this outcome cannot be ignored, it is 
noteworthy that none of the other random generation measures were significantly 
correlated with aspects of ecstasy use. Correlations between number of letters 
produced and other drugs were non significant.  
Thus combining the results of Studies 1 and 2, it is possible that while 
ecstasy/cannabis related deficits are apparent in memory updating, and deficits in 
access to semantic memory are a product of cocaine use, ecstasy use or a combination 
of the two, the other executive components may be not be susceptible to the effects of 
ecstasy/polydrug use.  
It is known that MDMA affects both serotonergic and dopaminergic systems 
(e.g. Kish et al, 2002), while cocaine may affect dopaminergic networks (Volkow et 
al. 2001) and cannabis the dopaminergic system (through interaction between the 
endocannabinoid and dopaminergic system, Ng Cheong Ton & Gardner 1986; 
Giuffrida et al. 1999). Thus this data is consistent with functional neuroimaging 
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studies indicating that ecstasy/polydrug-related neurotransmitter changes may be 
concentrated in the dorsolateral and parietal regions of the prefrontal cortex (Cohen et 
al, 1996), and in addition may give rise to significantly lower grey matter 
concentrations in multiple brain regions (bilateral BA 18 and cerebellum, left BA 21 
and left BA 45, as well as the midline brainstem; Cowan et al. 2003). Memory 
updating has been particularly linked to the dorsolateral prefrontal cortex (Goldman-
Rakic, 1996) while performance on the letter-updating task is most strongly 
associated with the left fronto-polar cortex (Van-der-Linden et al, 1999). Lesion 
studies have also implicated the left dorsolateral prefrontal cortex in impaired letter 
and category-based fluency (Stuss et al, 1998) and in impaired fluency among 
children (Levine et al, 2001). So it is likely that the deficits observed in the present 
study reflect reduced serotonergic/dopaminergic functioning in the prefrontal cortex. 
Although outside the scope of this study, it is possible that while ecstasy may affect 
memory updating and access through serotonergic depletions in the dorsolateral and 
parietal prefrontal regions (Cohen et al, 1996), cannabis may affect hippocampal areas 
resulting in deficits in short-term memory (e.g. Solowij et al, 1992; Solowij et al, 
2002). Therefore, future research should concentrate on investigating the differential 
effects of each recreational drug on the different cognitive functions.  
As with most studies in this area, there are a number of limitations. Due to the 
quasi-experimental design of the study, it is possible that the groups in each study 
may have differed on some variable other than ecstasy use. Some possibilities have 
been excluded such as intelligence (NART and Raven’s) and aspects of sleep quality. 
Clearly there were differences in the use of other illicit drugs. Group differences in 
other variables such as general health, nutrition, or some premorbid condition 
predating drug use (Verheul, 2001) cannot be ruled out; neither could we guarantee 
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the purity of the tablets consumed by the ecstasy users in the present studies (Cole et 
al, 2002a); though in a recent review of the literature, Parrot (2004) reports that 
analysis of the contents of ecstasy tablets from amnesty bins in nightclubs revealed 
that purity of tablets is approaching 100% MDMA. Furthermore, due to limited 
resources we were unable to provide an objective measure of recent drug use (e.g. 
from hair or urine samples). However, most published studies testing cognitive 
deficits among ecstasy users have not used these techniques (e.g. Fox et al, 2002; 
Morgan, 1998; Morgan, 1999; Rodgers, 2000). All participants reported being drug 
free for at least 7 days (mean abstinence period was actually over 5 weeks for both 
groups, median abstinence period over 2 weeks), and we have no reason to believe 
this information to be false (participants were not informed that they would be 
excluded prior to testing). Due to the unreliable nature of our sample, it was not 
possible to test all of the participants in Study 1 and 2 on measures to assess all four 
target executive functions. However, the samples were matched for age and 
intelligence, so we have no reason to believe that the results would be different had 
we used one group. The mean abstinence period was also longer for Study 2 than 
Study 1 (22 weeks compared to 5 weeks), but as the period of ecstasy intoxication 
should have long passed (and the median period was over 2 weeks in both studies), 
and serotonin levels risen again, we did not think that this was an important factor.  
The present studies provide further support for recent theoretical models of 
executive functioning suggesting that the central executive may not be a unified 
structure (e.g. Baddeley, 1996; Lehto et al, 1996 Miyake et al, 2000). Using a range of 
executive tasks to assess each of the four components, this study found that the effects 
of ecstasy/polydrug use on executive functions are not uniform, with ecstasy/polydrug 
users performing worse on the updating and access tasks, but not the shifting and 
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inhibition tasks which appear to be relatively unaffected by recreational 
ecstasy/polydrug use. This study highlights the importance of a multi-component 
approach to executive functions, not only in drug-related research, but in other 
neuropsychological testing populations, and is in line with other studies that provide 
support for the validity of this fragmented approach to executive functions (e.g. Fisk 
and Sharp, 2004).  
In conclusion, the findings presented here suggest that cognitive impairments 
in ecstasy users may also be related to the concomitant use of other drugs. By way of 
summary ecstasy-related deficits in memory updating and access to semantic memory 
are apparent, although both also seem to be related to aspects of cannabis and cocaine 
use respectively.   The study highlights the importance of a multicomponent approach 
to executive processes in samples of drug-users.  
 
 32 
References. 
Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW (2003) Stop-signal 
inhibition disrupted by damage to the right inferior frontal gyrus in humans. 
Nature Neuroscience 6: 115-6 
Baddeley AD (1996) Exploring the central executive. Quarterly Journal of 
Experimental Psychology 49A: 5-28 
Bhattachary S, Powell JH (2001) Recreational use of 3,4-
methylenedioxymethamphetamine (MDMA) or “ecstasy”: Evidence for 
cognitive impairment. Psychological Medicine 31: 647-658 
Bolla KI, McCann UD, Ricaurte GA (1998) Memory impairment in abstinent MDMA 
(“ecstasy”) users. Neurology 51: 1532-1537 
Bolla KI, Funderburk FR, Cadet JL (2000) Differential effects of cocaine and cocaine 
+ alcohol on neurocognitive performance. Neurology 54: 2285–2292 
Casey BJ, Trainor RJ, Orendi JL, Schubert AB, Nystrom LE, Giedd JN, Castellanos 
FX, Haxby JV, Noll DC, Forman SD, Dahl RE, Rapoport JL (1997) A 
developmental functional MRI study of prefrontal activation during 
performance of a go/no-go task. Journal of Cognitive Neuroscience 9: 835-847   
Cohen Z, Bonvento G, Lacombe P, Hamel E (1996) Serotonin in the regulation of 
brain microcirculation. Progress in Neurobiology 50: 335-362  
Cole J, Bailey M, Sumnall HR, Wagstaff GF, King LA (2002a) The content of ecstasy 
tablets: Implications for the study of their long-term effects. Addiction 97: 
1531-1536  
Cole J, Sumnall H, Grob C (2002b) Sorted: Ecstasy facts and fiction. The 
Psychologist 15(9): 464-467  
 33 
Cowan RL, Lyoo IK, Sung SM, Ahn KH, Kim MJ, Hwang J, Haga E, Vimal RLP, 
Lukas SE, Renshaw PF (2003) Reduced cortical gray matter density in human 
MDMA (ecstasy) users: a voxel-based morphometry study. Drug and Alcohol 
Dependence 72: 225-235 
Croft RJ, Mackay AJ, Mills ATD, Gruzelier JGH (2001) The relative contributions of 
ecstasy and cannabis to cognitive impairment. Psychopharmacology 153: 373-
379 
Curran HV, Travill RA (1997) Mood and cognitive deficits of 3,4-
methylenedioxymethamphetamine (MDMA “ecstasy”): Weekend “high” 
followed by mid-week low.  Addiction 92: 821.831 
Curran HV, Verheyden SL (2003) Altered response to tryptophan supplementation 
after long-term abstention from MDMA (ecstasy) is highly correlated with 
human memory function. Psychopharmacology 169(1): 91-103 
Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological 
basis: Neuroimaging evidence for the involvement of the frontal cortex. 
American Journal of Psychiatry 159: 1642–1652 
Fillmore MT, Rush CR, Hays L (2002) Acute effects of oral cocaine on inhibitory 
control of behaviour in humans. Drug and Alcohol Dependence 67: 157–167 
Fisk JE, Montgomery C, Murphy P, Wareing M (2004) Evidence of executive deficits 
among users of MDMA (Ecstasy). British Journal of Psychology 95: 457-466 
Fisk JE, Sharp C (2004) Age-related impairment in executive functioning: Updating, 
inhibition, shifting, and access. Journal of Clinical and Experimental 
Neuropsychology 26: 
Fisk JE, Warr P (1996) Age and Working memory: the role of perceptual speed, the 
Central Executive and the phonological loop. Psychology and Ageing 11(2): 
 34 
316-323 
Fox HC, Parrot AC, Turner JJD (2001) Ecstasy use: cognitive deficits related to 
dosage rather than self reported problematic use of the drug. Journal of 
Psychopharmacology 15: 273-281  
Fox HC, McLean A, Turner JJD, Parrott AC, Rogers R, Sahakian BJ (2002) 
Neuropsychological evidence of a relatively selective profile of temporal 
dysfunction in drug-free MDMA (“ecstasy”) polydrug users. 
Psychopharmacology 162: 203-214  
Giuffrida A, Parsons LH, Kerr TM, Rodriguez de Fonesca F, Navarro M, Piomelli D 
(1999) Dopamine activation of endogeneous cannabinoid signalling in the 
dorsal striatum. Nature Neuroscience 2:358-363 
Goldman-Rakic PS (1996) The prefrontal landscape: Implications of functional 
architecture for understanding human mentation and the central executive. 
Philosophical Transactions of the Royal Society of London 351: 1445-1453  
Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HK, 
Fimm B, Sass H (2000) Impaired cognitive performance in drug free users of 
recreational ecstasy (MDMA). Journal of Neurology, Neurosurgery and 
Psychiatry 68: 719-725  
Heffernan TM, Jarvis H, Rodgers J, Scholey AB, Ling J (2001) Prospective memory, 
everyday cognitive failure and central executive function in recreational users 
of Ecstasy. Hum Psychopharm Clin Exp 16 (8): 607-612  
Hinkle DE, Wiersma W, Jurs SG (1994) Applied Statistics for the Behavioral 
Sciences (3
rd
 ed.). Boston MA: Houghton Mifflin Company 
Jacobsen LK, Mencl WE, Pugh KR, Skudlarski P, Krystal JH (2003) Preliminary 
evidence of hippocampal dysfunction in adolescent MDMA ('ecstasy') users: 
 35 
possible relationship to neurotoxic effects. Psychopharmacology  173: 383-
390 
Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth 
Sleepiness Scale. Sleep 14: 540–545  
Kish SJ (2002) How strong is the evidence that brain serotonin neurons are damaged 
in human users of ecstasy? Pharmacology, Biochemistry and Behaviour 71: 
845-855  
Kiefer M, Marzinzik F, Weisbrod M, Scherg M, Spitzer M (1998) The time course of 
brain activations during response inhibition: evidence from event-related 
potentials in a go/no-go task. Neuroreport 9: 765-770  
Klugman A, Hardy S, Baldeweg T, Gruzelier J (1999) Toxic effect of MDMA on 
brain serotonin neurons. Lancet 353: 1269-1270 
Kolb B, Whishaw IQ (1985) Fundamentals of Human Neuropsychology (2
nd
 Ed). 
New York NY: WH Freeman & Co 
Lawton-Craddock A, Nixon SJ, Tivis R (2003) Cognitive efficiency in stimulant 
abusers with and without alcohol dependence, Alcohol Clin. Exp. Res. 27(3): 
457–464  
Lehto J (1996) Are executive function tests dependent on working memory capacity? 
Quarterly Journal of Experimental Psychology 49(A): 29-50  
Levin HS, Song J, Ewing-Cobbs L, Chapman SB, Mendelsohn D (2001) Word 
fluency in relation to severity of closed head injury, associated frontal brain 
lesions, and age at injury in children. Neuropsychologia 39(2): 122-131  
Liechti ME, Gamma A, Vollenweider FX (2001) Gender differences in the subjective 
effects of MDMA. Psychopharmacology 154: 161-168  
 36 
McCann UD, Ridenour A, Shaham Y, Ricaurte GA (1994) Serotonin Neurotoxicity 
after 3,4- Methylenedioxymethamphetamine (MDMA; ecstasy): a controlled 
study in humans. Neuropsychopharmacology 10: 129-138  
McCardle K, Luebbers S, Carter JD, Croft RJ, Stough C (2004) Chronic MDMA 
(ecstasy) use, cognition and mood. Psychopharmacology 173(3-4): 434-9  
McDowell DM, Kleber HD (1994) MDMA: Its history and pharmacology. Psychiatric 
Annals 24: 127-130  
Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, Wager TD (2000) 
The unity and Diversity of executive functions, and their contributions to 
complex “frontal lobe” tasks: A latent variable analysis. Cognitive Psychology 
41(1): 49-100  
Montgomery C, Fisk JE, Newcombe R (2004) Further evidence for deficits in the 
updating executive component process of working memory in users of 
MDMA (Ecstasy). Proceedings of the British Psychological Society 12: 70 
Montgomery C, Fisk JE, Newcombe R (in press) The Nature of Ecstasy-group related 
differences in Associative learning. Psychopharmacology  
Montgomery C, Fisk JE, Newcombe R, Wareing M, Murphy PN (2005) Syllogistic 
reasoning performance in MDMA (ecstasy) users. Experimental and Clinical 
Psychopharmacology, 13. 
Morgan MJ (1998) Recreational use of “ecstasy” (MDMA) is associated with 
elevated impulsivity. Neuropsychopharmacology 19: 252-264 
 37 
Morgan MJ (1999) Memory deficits associated with recreational use of  “ecstasy”  
(MDMA). Psychopharmacology 141: 30-36 
Morgan MJ (2000) Ecstasy  (MDMA): A review of its possible persistent 
psychological effects. Psychopharmacology 152: 230-248 
Morgan MJ, McFie L, Fleetwood LH, Robinson JA (2002) Ecstasy (MDMA): Are the 
psychological problems associated with it’s use reversed by prolonged 
abstinence? Psychopharmacology 159: 294-303  
Morris N, Jones DM (1990) Memory updating in working memory: The role of the 
central executive. British Journal of Psychology 81: 111–121  
Moulden DJA, Picton TW, Meiran N, Stuss DT, Riera JJ, Valdes-Sosa P (1998) 
Event-Related Potentials when switching attention between task-sets. Brain 
and Cognition 37: 186-190  
Nelson HE (1982) National Adult Reading Test (NART) Test Manual. Windsor, 
Berkshire, UK: NFER-Nelson 
Ng Cheong Ton JM, Gardner EL (1986) Effects of delta-9-tetrahydrocannabinol on 
dopamine release in the brain: intracranialmicrodialysis experiments. Social 
Neuroscience Abstracts 13:135 
Ornstein TJ, Iddon JL, Baldacchino AM, Sahakian BJ, London M, Everitt BJ, 
Robbins TW (2000) Profiles of cognitive dysfunction in chronic amphetamine 
and heroin abusers. Neuropsychopharmacology 23: 113–126 
Parrott AC (2000) Human Research on MDMA (3,4-Methylene- 
dioxymethamphetamine) Neurotoxicity: Cognitive and Behavioural Indices of 
Change. Neuropsychobiology 42: 17-24 
 38 
Parrot AC (2004) Is ecstasy MDMA? A review of the proportion of ecstasy tablets 
containing MDMA, their dosage levels, and the changing perceptions of 
purity. Psychopharmacology (Berl) 173(3-4): 234-41  
Posner MI, Raichle ME (1994) Images of Mind. New York, Sci. Am  
Raven J, Raven JC, Court JH (1998) Manual for Raven’s Progressive Matrices and 
Vocabulary Scales. Oxford, UK: Oxford Psychologists Press 
Reneman L, Majoie CBLM, Schmand B, van den Brink W, den Heeten GJ (2001) 
Pre-frontal N-acetylaspartate is strongly associated with memory performance 
in (abstinent) Ecstasy users: Preliminary report. Biological Psychiatry 50: 550-
554  
Reneman L, Booij J, Lavalaye J, de Bruin K, Reitsma JB, Gunning BW, den Heeten, 
GJ, van der Brink W (2002) Use of amphetamine by recreational users of 
ecstasy (MDMA) is associated with reduced striatal dopamine transporter 
densities: A [123I]beta-CIT SPECT study-preliminary report. 
Psychopharmacology (Berl) 159: 335–340 
Ricaurte GA, McCann UD (1992) Neurotoxic amphetamine analogues: effects in 
monkeys and implications for humans. Annals New York Academy of  
Sciences 648: 371-382  
Ricaurte GA, Yuan J, McCann UD (2000) (+/-)3,4-Methylenedioxymethamphetamine 
(`Ecstasy')-Induced Serotonin Neurotoxicity: Studies in Animals. 
Neuropsychobiology 42(1): 5-10  
Rodgers J (2000) Cognitive performance amongst recreational users of “ecstasy”. 
Psychopharmacology 151: 19-24 
Rogers RD, Monsell S (1995) Costs of a predictable Shift between simple cognitive 
tasks. Journal of Experimental Psychology: General 124: 207-231 
 39 
Rogers RD, Sahakian BJ, Hodges JR, Polkey CE, Kennard C, Robbins TW (1998) 
Dissociating executive mechanisms of task control following frontal lobe 
damage and parkinson’s disease. Brain 121: 815-842  
Roselli M, Ardila A (1996) Cognitive effects of cocaine and polydrug abuse. Journal 
of Clinical and Experimental Neuropsychology 18: 122–135 
Ruff RM, Light RH, Parker SB, Levin HS (1997) The psychological construct of 
word fluency. Brain and Language 57: 394-405  
Salthouse TA, Babcock RL (1991) Decomposing adult age differences in working 
memory. Developmental Psychology 27: 763-776  
Sankoh AJ, Huque MF, Dubey SD (1997) Some comments on frequently used 
multiple endpoint adjustment methods in clinical trials. Statistics in Medicine 
16: 2529-42 
Solowij N, Hall W, Lee N (1992) Recreational MDMA use in Sydney: a profile of 
'Ecstacy' users and their experiences with the drug. Br J Addict 87(8): 1161-72  
Solowij N, Stephens RS, Roffman RA, Kadden T, Miller R, Christiansen M, McRee 
K, Vendetti B (2002) Cognitive functioning of long-term heavy cannabis users 
seeking treatment. J. Am. Med. Assoc. 287: 1123–1131 
Strickland TL, Mena I, Villanueva-Meyer J, Miller BL, Cummings J, Mehringer CM, 
Satz P, Myers H (1993) Cerebral perfusion and neuropsychological 
consequences of chronic cocaine use. Journal of Neuropsychiatry and Clinical 
Neuroscience 5(4): 419-427 
Stuss DT, Alexander MP, Hamer L, Palumbo C, Dempster R, Binns M, Levine B, 
Izukava D (1998) The effects of focal anterior and posterior brain lesions on 
verbal fluency. Journal of International Neuropsychol Soc 4: 265-78 
 40 
Thomasius R, Petersen K, Buchert R, Andersen B, Zapletalova P, Wartberg L, 
Nebeling B, Schmoldt A (2003) Mood, cognition and serotonin transporter 
availability in current and former ecstasy (MDMA) users. 
Psychopharmacology 167(1): 85-96  
Turner JJD, Godolphin M, Parrot AC (1999) Cognitive Performance Profiles of 
current and former “ecstasy” (MDMA) users. Journal of Psychopharmacology 
13: A24  
Van der Linden M, Collette F, Salmon E, Delfiore G, Delgueldre C, Luxen A, Franck 
G (1999) The neural correlates of updating information in verbal working 
memory. Memory 7: 549-560  
Verdejo-Garcia AJ, Lopez-Torrecillas F, de Arcos AF, Perez-Garcia M (2005) 
Differential effects of MDMA, cocaine, and cannabis use severity on 
distinctive components of the executive functions in polysubstance abusers: A 
multiple regression analysis. Addictive Behaviours 30: 89-101   
Verheul R (2001) Co-morbidity of personality disorders in individuals with substance 
use disorders. European Psychiatry 16: 274-282  
Von Geusau NA, Stalenhoef P, Huizinga M, Snel J, Ridderinkhof KR (2004) 
Impaired executive function in male MDMA (“ecstasy”) users. 
Psychopharmacology 175: 331-341  
Verkes RJ, Gijsman HJ,  Pieters MSM, Schoemaker RC, Visser S, Kuijpers M et al 
(2001) Cognitive performance and serotonergic function in users of ecstasy. 
Psychopharmacology 153: 196-202 
Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D et al. 
(2001) Association of Dopamine transporter reduction with psychomotor 
 41 
impairment in methamphetamine abusers. American Journal of Psychiatry 
158:377-382 
Wareing M, Fisk JE, Murphy P (2000) Working memory deficits in current and 
previous users of MDMA (“ecstasy”). British Journal of Psychology 91: 181-
188 
Wareing M, Fisk JE, Murphy P, Montgomery C (2004a) Verbal working memory 
deficits in current and previous users of MDMA. Human 
Psychopharmacology: Clinical and Experimental 19: 225-234 
Wareing M, Murphy P, Fisk JE (2004b) Visuospatial memory impairments in users of 
MDMA ('ecstasy'). Psychopharmacology 173: 391-397 
 42 
Table 1 
Age, Years of Education, Intelligence and Sleep Quality for Ecstasy Users and 
Nonusers in Study 1.  
 
 
 
 
Ecstasy users  Non Ecstasy  
Users 
 
 
 
 
Mean S.D.      Mean S.D.  
Age (years) 
 
 
21.70 1.66 21.59 1.88 
Years of Education 
 
 
16.04 1.45 15.68 2.11 
Raven’s Progressive 
Matrices (maximum 60) 
 
50.37 3.84 48.08 5.08 
NART (maximum 50) 
 
 
29.93 6.23 30.32 6.25 
Hours Sleep per night 
 
 
8.04 1.64 7.93 1.47 
Epworth Sleep Scale 
(Maximum 24) 
 
6.88 3.34 5.32 2.52 
Self Report Health* 
 
 
3.74 0.81 3.94 0.89 
Letter Span Score 
 
 
5.22 0.58 5.26 0.75 
Weeks Since Last Used 
Ecstasy 
 
4.97 7.27 - - 
 
 
* The self report health measure scores range from 1 (very poor) to 5 (very good) 
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Table 2 
 
Significance Levels (F values) For Main Effects in Study 1. 
 
 
 
 
Ecstasy Users  Non Ecstasy Users  F 
 
 
Mean S.D. Mean S.D.  
 
Updating 
 
2.14 0.50 2.45 0.54 5.16** 
Computation Span 
 
3.85 1.63 4.50 1.19 3.22* 
Semantic Fluency 
 
40.59 9.03 41.94 10.11 0.29 
“S” Letter 
 
40.19 10.86 46.85 10.07 6.15** 
“C” Letter 
 
11.48 5.37 16.00 6.30 8.81*** 
 
 
 
 
 
*     p<.05, one-tailed 
**   p<.05, two-tailed 
*** p<.01, two-tailed 
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Table 3. 
 
Indicators of Drug Use Among Ecstasy Users and Non Ecstasy Users in Study 1.  
 
 Ecstasy 
Users 
  Non Ecstasy 
Users 
  
 Mean S.D. n Mean S.D. N 
Total Use       
   Ecstasy (Tablets) 345.96 365.76  27       - - - 
   Amphetamine (grams) 4.08 4.22 6 4 - 1 
   Cannabis (joints) 2634.18 2501.21 19 1317.41 1547.50 14 
   Cocaine (grams) 19.59 23.64 12 - - - 
       
Frequency of Use (times 
per week) 
      
   Ecstasy 0.44 0.36 27 - - - 
   Amphetamine 0.03 0.03 3 - - - 
   Cannabis 2.57 2.58 20 0.96 0.94 14 
   Cocaine 0.32 0.23 12 - - - 
       
Amount Used During  
Previous 30 Days 
      
   Ecstasy (tablets) 3.12 3.11 26 - - - 
   Amphetamine (grams) 2 3.46 3 - - - 
   Cannabis (joints) 22.66 36.04 19 9.58 11.66 13 
   Cocaine (grams) 1.68 1.83 10 - - - 
       
Average Weekly Dose       
   Ecstasy (tablets) 1.8 1.37 27 - - - 
   Amphetamine (grams) 0.12 0.23 6 0.01 - 1 
   Cannabis (joints) 10.17 9.19 18 6.40 11.00 14 
   Cocaine (grams) 
 
0.16 0.26 12 - - - 
       
Number Ever Used       
   Amphetamine 12 - - 1 - - 
   Cannabis 22 - - 18 - - 
   Cocaine 21 - - 4 - - 
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Table 4. 
 
Correlations between Measures and Indices of Drug Use: Study 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*  Correlation significant at p<.01 
 
 
 Ecstasy    Cannabis Cocaine Amphetamine 
Total use               N 
 
61 51 48 55 
Updating -.199 -.234 -.287 .034 
Computation span -.161 -.410* -.093 .128 
Semantic Fluency -.075 -.045 -.194 .132 
“S” letter -.326 -.208 -.365 .205 
“C” letter -.351* -.261 -.510* .109 
     
Frequency of Use N 
 
61 52 48 51 
Updating -.253 -.194 -.310 -.050 
Computation span -.168 -.398* -.027  .023 
Semantic Fluency -.045 -.029 -.231  .139 
“S” letter -.274 -.182 -.389*  .049 
“C” letter -.313 -.226 -.465*  .029 
     
Average dose        N 
 
61 50 48 54 
Updating -.230 -.196 -.276 -.026 
Computation span -.151 -.401* -.092  .146 
Semantic Fluency -.028  .002 -.180  .081 
“S” letter -.317 -.175 -.351  .154 
“C” letter -.347* -.204 -.505*  .087 
     
Current Use          N 
 
61 61 61 61 
Updating -.171 -.049 -.197  .015 
Computation span -.168 -.281 -.027 -.034 
Semantic Fluency -.018 -.079 -.246  .037 
“S” letter -.330* -.139 -.271 -.066 
“C” letter -.386* -.178 -.287 -.099 
     
Ever Used              N 
 
61 61 61 61 
Updating   .294   .163   .121  .028 
Computation span   .192   .331*   .146  .193 
Semantic Fluency   .044   .118   .096 -.049 
“S” letter   .309   .250   .291 -.068 
“C” letter   .368*   .210   .408*  .017 
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Table 5 
 
Age, Years of Education, Intelligence and Sleep Quality for Ecstasy Users and 
Nonusers in Study 2. 
 
 
 
 
Ecstasy users  Non Ecstasy  
Users 
 
 
 
 
Mean S.D.      Mean S.D.  
Age (years) 
 
 
21.96 2.11 20.83 1.45 
Years of Education 
 
 
15.62 1.94 15.07 1.92 
Raven’s Progressive 
Matrices (maximum 60) 
 
46.66 6.53 47.83 5.47 
NART (maximum 50) 
 
 
28.67 6.53 28.71 4.90 
Hours Sleep per night 
 
 
7.92 1.45 8.09 1.13 
Epworth Sleep Scale 
(Maximum 24) 
 
6.48 3.54 7.63 3.22 
Self Report Health* 
 
 
3.54 0.88 3.83 0.70 
Weeks Since Last Used  
Ecstasy 
 
22.15 40.71 - - 
 
 
* The self report health measure scores range from 1 (very poor) to 5 (very good) 
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Table 6 
 
Mean Scores and Significance Levels for Measures in Study 2. 
 
 
 Ecstasy 
Users 
 Non 
Ecstasy 
Users 
 F 
 Mean S.D. Mean S.D.  
Random Letter Generation 
(standardised scores) 
 
     
Alphabetic 
Sequences 
 
0.0568 0.7719 -0.0720 0.7821 0.63 
Repeat Sequences 
 
 
 0.0005 0.6453 -0.0007 0.6955 0.00 
Redundancy 
 
 
-0.0490 0.6341  0.0622 0.9591 0.45 
Number of Letters 
 
 
 0.1967 0.4203 -0.2495 1.0137 8.29*** 
Switching Tasks 
 
     
Plus/Minus task 
Switch Cost 
(seconds) 
28.63 19.46 29.58 18.18 0.06 
Number/Letter 
Switch Cost 
(seconds) 
39.27 18.14 38.52 18.98 0.04 
 
 
 
***   p<.01, two-tailed 
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Table 7. 
 
Indicators of Drug Use Among Ecstasy Users and Non Ecstasy Users in Study 2  
 
 
 Ecstasy 
Users 
  Non Ecstasy 
Users 
  
 Mean S.D. n Mean S.D. N 
Total Use       
   Ecstasy (Tablets) 373.87 542.91 52 - - - 
   Amphetamine (grams) 90.85 127.19 16 - - - 
   Cannabis (joints) 3544.16 4410.04 40 367.54 622.96 13 
   Cocaine (grams) 57.12 92.39 21 - - - 
       
Frequency of Use (times 
per week) 
      
   Ecstasy 0.27 0.29 52 - - - 
   Amphetamine 0.04 0.13 14 - - - 
   Cannabis 2.78 2.65 40 0.94 1.36 13 
   Cocaine 0.71 1.57 21 - - - 
       
Amount Used During  
Previous 30 Days 
      
   Ecstasy (tablets) 2.18 3.17 52 - - - 
   Amphetamine (grams) 0.04 0.13 14 - - - 
   Cannabis (joints) 41.14 59.45 40 17.29 42.97 12 
   Cocaine (grams) 0.83 0.87 21 - - - 
       
Average Weekly Dose       
   Ecstasy (tablets) 1.46 1.40 52 - - - 
   Amphetamine (grams) 0.26 0.37 14 - - - 
   Cannabis (joints) 9.10 11.58 40 1.91 3.37 13 
   Cocaine (grams) 
 
0.30 0.38 21 - - - 
       
Number Ever Used       
   Amphetamine 19 - - 0 - - 
   Cannabis 46 - - 23 - - 
   Cocaine 41 - - 4 - - 
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Table 8: Correlations between Measures and Indices of Drug Use. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Ecstasy    Cannabis Cocaine Amphetamine 
Total use               N 
 
93 76 67 85 
P/M switch cost -.015 -.136  .196  .106 
N/L switch cost  .124  .143  .212  .077 
Redundancy  .028 -.032  .051  .042 
Repeat sequence  .084  .004  .131  .139 
Alpha sequence  .080  .010  .113 -.137 
Number of Letters  .228  .174  .018  .032 
     
Frequency of Use N 
 
93 76 67 85 
P/M switch cost -.043 -.125  .108  .220 
N/L switch cost  .071  .050  .144  .139 
Redundancy -.079 -.145  .041  .034 
Repeat sequence -.062 -.169  .100  .044 
Alpha sequence  .106 -.110  .025 -.105 
Number of Letters  .335*  .186  .078 -.051 
     
Average dose        N 
 
93 76 67 83 
P/M switch cost -.025 -.167   .186  .115 
N/L switch cost  .060  .122   .210  .025 
Redundancy  .035 -.056   .048 -.029 
Repeat sequence  .053 -.017   .129  .097 
Alpha sequence  .071  .033   .120 -.159 
Number of Letters  .283*  .199   .018  .034 
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Table 8: continued 
Correlations between Measures and Indices of Drug Use. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*  Correlation significant at p<.01 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Ecstasy    Cannabis Cocaine Amphetamine 
Current Use          N 
 
93 93 93 93 
P/M switch cost -.106 -.045  .133  .197 
N/L switch cost  .041  .062  .068 -.025 
Redundancy -.109 -.100 -.057  .013 
Repeat sequence -.155 -.033  .075  .055 
Alpha sequence -.021 -.048  .062 -.071 
Number of Letters  .344*  .116  .000  .102 
     
Ever Used              N 
 
93 92 92 92 
P/M switch cost  .051  .118 -.007 -.073 
N/L switch cost -.063 -.062 -.176 -.052 
Redundancy  .028  .050 -.142  .077 
Repeat sequence -.022  .055 -.118 -.056 
Alpha sequence -.134  .069 -.029  .129 
Number of Letters -.258 -.037 -.018 -.023 
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1
 Those in the nonuser group who reported that they had ever used amphetamine or cocaine (N= 1 and 
4 respectively) felt that they were unable to estimate their pattern of use accurately. 
2
 Those in the nonuser group who reported that they had ever used amphetamine or cocaine (N= 1 and 
4 respectively) felt that they were unable to estimate their pattern of use accurately. 
 
 
